|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06108 NEW RAY MEDIC
Nominal 
0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 50,154 | -44.131% | 89,771 | 335,380 | 133,214 | 118,632 |
| Cost of Sales | (37,213) | -51.370% | (76,523) | (306,892) | (122,283) | (103,757) |
| Gross Profit | 12,941 | -2.317% | 13,248 | 28,488 | 10,931 | 14,875 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 423 | -- | -- | -- | (37,325) | (20,914) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 1,110 | 1,484 | 9,263 | |
| Profit / (Loss) before Taxation | (22,342) | -72.172% | (80,286) | (3,608) | (69,901) | (43,792) | |
| Taxation | 172 | -92.646% | 2,339 | 784 | 170 | (317) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (22,170) | -71.558% | (77,947) | (2,824) | (69,731) | (44,109) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (2,936) | 8.140% | (2,715) | (931) | (1,477) | (2,313) |
| Depreciation & Amortisation | 9,767 | -3.991% | 10,173 | 9,603 | 9,336 | 9,379 |
| Directors' Emoluments | 3,080 | -39.046% | 5,053 | 2,923 | 3,425 | 2,914 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Qualified | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -1.330 | -71.459% | -4.660 | -0.170 | -4.170 | -2.640 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.027) | -- | 0.000 | (0.035) | (0.019) | (0.034) |
| NBV per share ($) | 0.287 | -- | 0.314 | 0.378 | 0.362 | 0.391 |
| Remarks: | Real time quote last updated: 25/11/2024 07:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -4,088,000 |
| %Change | -69.394% |
| EPS / (LPS) | HKD -0.002 |
| NBV Per Share ($) | HKD 0.280 |